PMA device
Concerto/Insync Sentry/Insync Maximo Implantable Cardiovascular Defibrillators with Cardiac Resynchicnization
Medtronic Cardiac Rhythm Disease Management · Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK, Class III) · First FDA decision Jun 26, 2002, newest Jan 10, 2019Heart failureVentricular arrhythmia and sudden cardiac arrest
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
5
Naming "Concerto Insync Sentry"
MAUDE reports
0
Brand "Concerto Insync Sentry", since 2015
PubMed studies
0
Mentioning "Concerto Insync Sentry"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Concerto/Insync Sentry/Insync Maximo Implantable Cardiovascular Defibrillators with Cardiac Resynchicnization
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- CONCERTO/INSYNC SENTRY/INSYNC MAXIMO IMPLANTABLE CARDIOVASCULAR DEFIBRILLATORS WITH CARDIAC RESYNCHICNIZATIONPMA supplement
P010031-S657 · Decided Jan 10, 2019 · 50 days after receipt · Normal 180 Day Track No User Fee
Device type: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK) · Cardiology
- CONCERTO/INSYNC SENTRY/INSYNC MAXIMO IMPLANTABLE CARDIOVASCULAR DEFIBRILLATORS WITH CARDIAC RESYNCHICNIZATIONPMA supplement
P010031-S538 · Decided Aug 24, 2016 · 176 days after receipt · Normal 180 Day Track
Device type: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK) · Cardiology
P010031-S402 · Decided Nov 22, 2013 · 70 days after receipt · Normal 180 Day Track No User Fee
Device type: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
- Implantable Cardioverter Defibrillators (ICDs)National analysisReview closedCAG-00157NUpdated Sep 15, 2026
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R2Updated Nov 19, 2026
- Wireless Stimulation Endocardially for Cardiac Resynchronization Therapy System (WiSE CRT)National analysisReview closedCAG-00471NUpdated Nov 18, 2026
- Implantable Defibrillators - Clinical TrialsNational analysisReview closedCAG-00157RUpdated Sep 15, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R3Updated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Concerto Insync Sentry", any status and sponsor, newest update first.
Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
NCT00157846 · 36 participants · Start Oct 2003 · Primary completion Aug 2008
Device: CRT-P or CRT-D Device · For: Heart Failure, Congestive
Sites: Augsburg, Germany; Berlin, Germany; Bernau, Germany · 10 sites in all
Charles Porter, MDAcademic, hospital or other
NCT02134379 · 11 participants · Start Apr 2014 · Primary completion Jan 2016
Device: Medtronic ICDs, CRT-Ds, and CRT-Ps · For: Heart Failure; With Decompensation
Sites: Kansas City, Kansas
- Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart FailurePivotal-lookingCompleted
Silesian Centre for Heart DiseasesAcademic, hospital or other
NCT00814840 · 100 participants · Start Feb 2008 · Primary completion Jul 2010
Device: Cardiac resynchronization pacemaker (InSync Sentry or Concerto, Medtronic, Minneapolis, MN,USA) with two intracardiac leads; Triple-site cardiac resynchronization · For: Congestive Heart Failure; Heart Disease
Sites: Zabrze, Poland
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Concerto Insync Sentry", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NIK
127,080 reports: 63,286 malfunction, 61,191 injury, 2,565 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2127-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Z-2128-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-1525-2021 · Started Apr 6, 2021
Reason given: A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other device features or therapies are impacted.
Cause as FDA categorized it: Software design · Device type: Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)
8 more recall records with a free account
Published research
The most relevant PubMed records for "Concerto Insync Sentry"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NIK.
- Amplia MRI CRT-DMedtronic Cardiac Rhythm Disease Management · PMA 2022
- Promote/+/RF/QAbbott Medical · PMA 2026
- Contak CDBoston Scientific Corp · PMA 2022
- Frontier/Frontier Ii/Anthem Family of Crt-PsAbbott Medical · PMA 2016
- Microny Family of PacemakersAbbott Medical · PMA 2016
- Sensolog/Dialog/Regency Family of PacemakersSt. Jude Medical, Inc. · PMA 2016
- Contak Cd,easytrakBoston Scientific Corp · PMA 2026
- Quadra Assura/Unify Assura Family of Crt-DsAbbott Medical · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.